Does Alpelisib need to be taken long-term?

Alpelisib (Alpelisib) is usually designed as a long-term oral drug, mainly used to treat hormone receptor-positive (HR-positive), HER2-negative advanced breast cancer, especially those with PIK3CA gene mutations. Because the mechanism of action of Apelvis involves inhibiting the PI3K signaling pathway, which plays an important role in a variety of cancers, this drug usually requires long-term use to maintain therapeutic effects.

While patients are taking Apelvis, doctors will conduct regular monitoring and evaluation based on the patient's condition, treatment response, and drug tolerance. The goal of treatment is to prolong the patient's progression-free survival (PFS) and improve the survival rate. Therefore, while achieving the therapeutic effect, it is necessary to ensure the patient's quality of life and adjust the treatment plan in a timely manner.

Although Apelvis is designed for long-term use, the specific treatment regimen and schedule are still individualized and depend on the patient's specific situation. During the use of Apelvis, doctors may consider some factors, such as the progression of the disease, the patient's overall health, the occurrence of side effects, etc., to decide whether the treatment plan needs to be adjusted.

Patients should pay close attention to their doctor's advice while taking Apelvis and have regular follow-up visits. Any possible side effects, discomfort or other changes should be reported to the doctor promptly so that the doctor can intervene and adjust the treatment plan in a timely manner.

Apelis has not yet been launched in China, so it is not included in medical insurance. Therefore, patients cannot purchase it domestically and need to purchase Apelis through overseas channels. In foreign countries, the original Apelvis drug is mainly used. There are European and Indian versions of the original drug on the market. The price of the European version of the original drug is as high as tens of thousands of yuan. Relatively speaking, the price of the Indian version of the original drug is around four to five thousand yuan. The price is still relatively cheap. Moreover, the ingredients and efficacy of the European and Indian original drugs are consistent.